Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-02-03
2000-11-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514375, 514414, 514417, 514466, 564158, 549441, 548221, 548454, 548455, 548477, A61K 3116, A61K 3136, C07D31744, C07D20948, C07D20902
Patent
active
061504165
ABSTRACT:
The present invention provides non-peptide cathepsin D binding compounds and methods for using such compounds in the detection, labelling and inhibition of cathepsin D.
REFERENCES:
Flynn et al., Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition, Journal of the American Chemical Society, vol. 119, No. 21, pp. 4874-4881, May 1997.
Adams, et al., "Novel Inhibitors of the Proteasome and Their Therapeutic Use in Inflammation," Ann. Rep. Med. Chem., 31:279-288 (1996).
Agarwal, et al., "Inhibition of Cathepsin D by Substrate Analogues Containing Statine and by Analogues of Pepstatin," J. Med. Chem., 29:2519-2524 (1986).
Baldwin, et al., "Crystal structures of native and inhibited forms of human cathepsin D: Implications for lysosomal targeting and drug design," Proc. Natl. Acad. Sci. USA, 90:6796-6800 (1993).
Edmunds, et al., "Thrombin and Factor Xa Inhibition," Ann. Rep. Med. Chem., 31:51-60 (1996).
Getman, et al., "Discovery of a Novel Class of Potent HIV-1 Protease Inhibitors Containing the (R)-(Hydroxyethyl) urea Isostere," J. Med. Chem., 36:288-291 (1993).
Jupp, et al., "The selectivity of statine-based inhibitors against various human aspartic proteinases," Biochem. J., 265:871-878 (1990).
Kick, et al., "Expedient Method for the Solid-Phase Synthesis of Aspartic Acid Protease Inhibitors Directed toward the Generation of Libraries," J. Med. Chem., 38:1427-1439 (1995).
Kick, et al., "Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D," Chemistry & Biology, 4(4):297-307 (1997).
Krafft, et al., "Synthetic Approaches to Continuous Assays of Retroviral Proteases," Methods in Enzymol., 241:70-86 (1994).
Miller, "Regulation of Apoptosis by Members of the ICE Family and the Bcl-2 Family," Ann. Rep. Med. Chem., 31:249-268 (1996).
Westley, et al., "Cathepsin D and Breast Cancer," Eur. J. Cancer, 32:15-24 (1996).
Wiley, et al., "Peptidomimetics Derived from Natural Products," Med. Res. Rev., 13:327-384 (1993).
Ellman Jonathan A.
Kick Ellen K.
Kuntz Irwin D.
Lee Christina E.
Liu Guangcheng
Coleman Brenda
Shah Mukund J.
The Regents of the University of California
LandOfFree
Nanomolar, non-peptide inhibitors of cathepsin D does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanomolar, non-peptide inhibitors of cathepsin D, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanomolar, non-peptide inhibitors of cathepsin D will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257915